高级检索
当前位置: 首页 > 详情页

Urinary Bile Acid Profile of Newborns Born by Cesarean Section Is Characterized by Oxidative Metabolism of Primary Bile Acids: Limited Roles of Fetal-Specific CYP3A7 in Cholate Oxidations.

文献详情

资源类型:
Pubmed体系:
机构: [1]Key laboratory of Drug Targeting and Drug Delivery System, Ministry of Education, West China School of Pharmacy,Sichuan University, Chengdu, China [2]Evidence-Based Pharmacy Center, Department of Pharmacy, West China Second University Hospital.Sichuan University, Chengdu, China [3]Labor And Delivery Room, West China Second University Hospital,Sichuan University, Chengdu, China [4]Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education,Sichuan University, Chengdu, China [5]Institute of Clinical Pharmacology, West China Hospital,Sichuan University, Chengdu, China [6]Metabolomics Shared Resource, University of Hawaii Cancer Center, Honolulu, Hawaii [7]State Key Laboratory of Drug Delivery Technology and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research, Tianjin, China [8]Chengdu Health-Balance Medical Technology Co., Ltd., Chengdu, China
出处:
ISSN:

摘要:
This work aims to investigate how the bile acid metabolism of newborns differs from that of adults along the axis of primary, secondary, and tertiary bile acids (BAs). The total unconjugated BA profiles were quantitatively determined by enzyme digestion techniques in urine of 21 newborns born by cesarean section, 29 healthy parturient women, 30 healthy males, and 28 healthy nonpregnant females. As expected, because of a lack of developed gut microbiota, newborns exhibited poor metabolism of secondary BAs. Accordingly, the tertiary BAs contributed limitedly to the urinary excretion of BAs in newborns despite their tertiary-to-secondary ratios significantly increasing. As a result, the primary BAs of newborns underwent extensive oxidative metabolism, resulting in elevated urinary levels of some fetal-specific BAs, including 3-dehydroCA, 3β,7α,12α-trihydroxy-5β-cholan-24-oic acid, 3α,12-oxo-hydroxy-5β-cholan-24-oic acid, and nine tetrahydroxy-cholan-24-oic acids (Tetra-BAs). Parturient women had significantly elevated urinary levels of tertiary BAs and fetal-specific BAs compared with female control, indicating that they may be excreted into amniotic fluid for maternal disposition. An in vitro metabolism assay in infant liver microsomes showed that four Tetra-BAs and 3-dehydroCA were hydroxylated metabolites of cholate, glycocholate, and particularly taurocholate. However, the recombinant cytochrome P450 enzyme assay found that the fetal-specific CYP3A7 did not contribute to these oxidation metabolisms as much as expected compared with CYP3A4. In conclusion, newborns show a BA metabolism pattern predominated by primary BA oxidations due to immaturity of secondary BA metabolism. Translational studies following this finding may bring new ideas and strategies for both pediatric pharmacology and diagnosis and treatment of perinatal cholestasis-associated diseases. SIGNIFICANCE STATEMENT: The prenatal BA disposition is different from adults because of a lack of gut microbiota. However, how the BA metabolism of newborns differs from that of adults along the axis of primary, secondary, and tertiary BAs remains poorly defined. This work demonstrated that the urinary BA profiles of newborns born by cesarean section are characterized by oxidative metabolism of primary BAs, in which the fetal-specific CYP3A7 plays a limited role in the downstream oxidation metabolism of cholate. Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics.

语种:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 2 区 医学
小类 | 2 区 药学
最新[2023]版:
大类 | 3 区 医学
小类 | 2 区 药学
第一作者:
第一作者机构: [1]Key laboratory of Drug Targeting and Drug Delivery System, Ministry of Education, West China School of Pharmacy,Sichuan University, Chengdu, China [8]Chengdu Health-Balance Medical Technology Co., Ltd., Chengdu, China
共同第一作者:
通讯作者:
通讯机构: [1]Key laboratory of Drug Targeting and Drug Delivery System, Ministry of Education, West China School of Pharmacy,Sichuan University, Chengdu, China [8]Chengdu Health-Balance Medical Technology Co., Ltd., Chengdu, China [*1]West China School of Pharmacy,Sichuan University, No.17 People’s South Road, Chengdu 610041, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号